Similar articles for PMID: 33443068

Year	Number of Results
2004	1
2012	2
2013	3
2014	3
2015	13
2016	15
2017	17
2018	24
2019	17
2020	22
2021	9
2022	8
2023	1
2024	0

1

⁶⁸Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.

Carlucci G, Ippisch R, Slavik R, Mishoe A, Blecha J, Zhu S. Carlucci G, et al. J Nucl Med. 2021 Feb;62(2):149-155. doi: 10.2967/jnumed.120.260455. Epub 2020 Dec 18. J Nucl Med. 2021. PMID: 33443068 Free PMC article.

2

FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging.

Masters SC, Hofling AA, Gorovets A, Marzella L. Masters SC, et al. Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):27-28. doi: 10.1016/j.ijrobp.2021.03.055. Epub 2021 Apr 20. Int J Radiat Oncol Biol Phys. 2021. PMID: 33857629 No abstract available.

3

Potential Impact of ⁶⁸Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.

Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG. Calais J, et al. J Nucl Med. 2018 Nov;59(11):1714-1721. doi: 10.2967/jnumed.118.209387. Epub 2018 Apr 13. J Nucl Med. 2018. PMID: 29653978 Free PMC article. Clinical Trial.

4

Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA.

Sartor O, Hope TA, Calais J, Fendler WP. Sartor O, et al. J Nucl Med. 2021 Feb;62(2):146-148. doi: 10.2967/jnumed.120.261834. J Nucl Med. 2021. PMID: 33468543 Free article. No abstract available.

5

Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.

Yilmaz B, Turkay R, Colakoglu Y, Baytekin HF, Ergul N, Sahin S, Tugcu V, Inci E, Tasci AI, Cermik TF. Yilmaz B, et al. Prostate. 2019 Jun;79(9):1007-1017. doi: 10.1002/pros.23812. Epub 2019 Apr 23. Prostate. 2019. PMID: 31012125

6

Frusemide aids diagnostic interpretation of ⁶⁸ Ga-PSMA positron emission tomography/CT in men with prostate cancer.

Fennessy N, Lee J, Shin J, Ho B, Ali SA, Paschkewitz R, Emmett L. Fennessy N, et al. J Med Imaging Radiat Oncol. 2017 Dec;61(6):739-744. doi: 10.1111/1754-9485.12625. Epub 2017 Jun 17. J Med Imaging Radiat Oncol. 2017. PMID: 28623852

7

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.

Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, Christidis D, Bolton D, Hofman MS, Lawrentschuk N, Murphy DG. Perera M, et al. Eur Urol. 2020 Apr;77(4):403-417. doi: 10.1016/j.eururo.2019.01.049. Epub 2019 Feb 14. Eur Urol. 2020. PMID: 30773328

8

The Academic NDA: Justification, Process, and Lessons Learned.

Sunderland JJ. Sunderland JJ. J Nucl Med. 2020 Apr;61(4):480-487. doi: 10.2967/jnumed.119.238287. Epub 2020 Feb 7. J Nucl Med. 2020. PMID: 32034112 Free article.

9

Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer.

Park SY, Zacharias C, Harrison C, Fan RE, Kunder C, Hatami N, Giesel F, Ghanouni P, Daniel B, Loening AM, Sonn GA, Iagaru A. Park SY, et al. Radiology. 2018 Aug;288(2):495-505. doi: 10.1148/radiol.2018172232. Epub 2018 May 22. Radiology. 2018. PMID: 29786490

10

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year